MC4R Deficiency: The Most Common Genetic Obesity Cause Often Goes Undiagnosed for Decades | Research

The takeaway

A multigenerational case of MC4R deficiency illustrates how monogenic obesity is underdiagnosed, with patients enduring decades of failed treatments before genetic testing reveals a treatable cause.

Decades undiagnosed
The most common genetic cause of severe obesity often goes undiagnosed for years as patients receive inappropriate treatments

What the researchers found

MC4R deficiency caused multigenerational severe obesity diagnosed only after decades of failed treatments, highlighting the need for early genetic testing and availability of targeted melanocortin therapies.

Why it matters

About 5% of severely obese individuals may have MC4R mutations. Diagnosing them enables targeted treatment with melanocortin pathway drugs instead of futile dietary interventions.

How the study worked

Detailed multigenerational case report with genetic testing, clinical history, treatment outcomes, and therapeutic implications.

What this study cannot tell us

Single family case report. Genetic testing availability and cost vary globally. Not all MC4R variants respond equally to melanocortin agonists.

How to read the evidence

Multigenerational case report providing important clinical lessons. Illustrative rather than statistically generalizable.

When this study was published

Published in 2025.

The bigger picture

This case epitomizes the need for precision medicine in obesity: genetic testing can identify patients who need specific peptide-pathway-targeting drugs instead of generic weight loss approaches.

Questions still open

Should all severely obese children undergo MC4R genetic testing?
How effective is setmelanotide in different MC4R variant types?
Could GLP-1 drugs complement melanocortin therapy for MC4R patients?

Common questions

What is MC4R deficiency?

MC4R (melanocortin 4 receptor) deficiency is a genetic condition where a mutation in a single gene causes severe obesity from early childhood. It is the most common single-gene cause of obesity, affecting about 5% of severely obese individuals.

Is there a treatment for genetic obesity?

Yes. Setmelanotide is a drug that activates the melanocortin pathway downstream of the genetic defect, helping some patients with MC4R and related mutations manage their weight. Genetic testing is needed to identify eligible patients.

Read the original research

Monogenic obesity due to MC4R deficiency: lessons from a multigenerational case.

Molecular and cellular pediatrics, 13(1), 3

View on PubMed ↗Publisher’s paper ↗

Citation

Giannopoulou, Eleni Z; Zorn, Stefanie; Schirmer, Melanie; Brandt-Heunemann, Stephanie; Schnurbein, Julia von; Nestoris, Claudia; Moawia, Abubakar; Siebert, Reiner; Denzer, Christian; Wabitsch, Martin. (2026). Monogenic obesity due to MC4R deficiency: lessons from a multigenerational case.. Molecular and cellular pediatrics, 13(1), 3. https://doi.org/10.1186/s40348-025-00214-z